MMR 2035FR

American Express Company (AXP): analysis and signal as of September 7, 2026

Exchange : NYSE · Sector : Finance

In short

The signal is weak with a score of -2,0. The main reason is the divergence between solid results and a penalizing macroeconomic context.

Current signal
weak (vote 3/3)
Deterministic score
-2.0 → signal expected by the scale : no signal (September 10, 2026)
Layers
fundamentals : positive, price : positive, risks : positive

Triggered rules

RuleWeight
penalizes a PEG above 2, the anticipated growth is overpaid (overvalued fast grower)-1.5
penalizes direct holding of US securities in a CTO (US estate tax at death), favors a UCITS ETF domiciled in IE-1.0
moderately favors a positive 12-1 month momentum (tailwind), BUT guardrail: costly rotation, long-term reversal, momentum crashes, a conviction signal, not a rotation trigger+0.5

Thesis

American Express Company combines a broad competitive advantage and inherent accounting quality. The macro regime penalizes premium consumption and rate sensitivity. The stock is down 15,7 % from its late 2025 peak. Retail flow supports the stock but not institutional flow. The invalidation is broken because the CFPB case on late fees is not clarified.

Bull case

2026 guidance is raised with revenue growth at 10 %. EPS is 17,30 to 17,90 USD. The share buyback program amounts to 16 Md$ plus 10 Md$. T2 2026 EPS is 4,53 USD, which is +11 % year on year. TTM PER is 20,4 versus 24,0 at the end of 2025. The dividend yield is 1,17 % with 3,54 USD per year, up 15,9 %.

Bear case

The macro regime is in expansion with US inflation at 3,5 % off target. US 10-2 rates are at +0,41 pt. This context penalizes discretionary consumption and rate-sensitive values. T2 2026 EPS of 4,53 USD is below the consensus of 4,71 USD. The stock fell 5 % post-results. Intraday flow is negative over 6 months at -7,5 %, a sign of fragility if retail flow dries up.

Scenarios

The bullish scenario has a 35 % probability with a target of 374,73 USD and +14,9 % margin. The central scenario has a 45 % probability with a consolidation between 300 and 340 USD pending T3 in mid-October. The bearish scenario has a 20 % probability with a max loss of -15 % toward 275 USD if T3 disappoints or if consumer credit stress worsens.

Risks

The main risk is rate sensitivity in an expansion regime with off-target inflation. T2 2026 EPS is below consensus. The stock fell 5 % post-results. Intraday flow is negative over 6 months. The CFPB case on late fees is not clarified.

Market positioning (short sellers)

Short interest / shares outstanding
2.08 %
Days to cover
4.99
Settlement date
2026-08-14
Source
FINRA (disseminated on 2026-08-26)

Market information published by FINRA (consolidated short interest, all venues), no directional comment.

Upcoming catalysts

DateDescription
T3 2026 publication and update on international spending volumes and Net Promoter Score

Signal history (last 12 months)

DateSignalNew fact
weak (3/3)not published
weak (3/3)The deterministic score remains at -2,00 with the same rules triggered (fis-estate-tax-us -1,0, cm-lynch-peg-excessif -1,5, ff-momentum-12-1 +0,5). None of the three layers brought new dated and quantified facts. SEC EDGAR endpoints, AXP IR, and several financial pages remain inaccessible during this session, which forbids any revision of the prior verdict. The points marked [perime possible] in the fundamental, technical, and sentiment layers do not constitute p
weak (single draw, outside the three-draw protocol)unchanged

Frequently asked questions

What is the signal and the score?

The signal is weak with a vote of 3/3 and a score of -2,0. This verdict is based on a closed-loop model under Fed and OCC supervision. Accounting quality is historically good under US GAAP. A share buyback program and a dividend are in place.

Why is the stock in a pullback?

The stock is down 15,7 % from its late 2025 high. Intraday performance is negative at 7,5 % over 6 months. This pullback occurs despite EPS up 18,9 % year on year and raised guidance to 10 %. The financial sector is penalized by rate sensitivity.

What are the bullish arguments?

2026 guidance is raised with revenue growth at 10 %. EPS is 17,30 to 17,90 USD. The share buyback program is 16 Md$ plus 10 Md$. T2 2026 EPS is 4,53 USD, which is +11 % year on year. TTM PER is 20,4 versus 24,0 at the end of 2025. The dividend yield is 1,17 % with 3,54 USD per year, up 15,9 %.

What are the bearish arguments?

The macro regime is in expansion with US inflation at 3,5 % off target. US 10-2 rates are at +0,41 pt. This context penalizes discretionary consumption and rate-sensitive values. T2 2026 EPS of 4,53 USD is below the consensus of 4,71 USD. The stock fell 5 % post-results. Intraday flow is negative over 6 months at -7,5 %.

What are the possible scenarios?

The bullish scenario has a 35 % probability with a target of 374,73 USD and +14,9 % margin. The central scenario has a 45 % probability with a consolidation between 300 and 340 USD pending T3 in mid-October. The bearish scenario has a 20 % probability with a max loss of -15 % toward 275 USD if T3 disappoints or if consumer credit stress worsens.

Sources

The official filings below are the issuer's own, matched to this stock by its identifier (LEI, CIK or ISIN). The figures quoted above come from an automated arbitration: they have not been re-checked one by one.

Automated AI analysis: limitations and transparency

  • This content is an automated analysis produced using artificial intelligence. Personal analysis for information purposes — no personalised investment advice. MMR content consists of general research. It does not take account of your financial circumstances, objectives or risk tolerance. Data, analyses and results, including those produced using artificial intelligence, may contain errors, be incomplete or become outdated. No return or outcome is guaranteed. All investments carry a risk of partial or total loss of capital. Past performance and simulations do not predict future results. Before making any decision, check information against original sources and, where necessary, consult an authorised professional. You remain responsible for your investment decisions. This notice does not exclude or limit any liability that cannot legally be excluded or limited.
  • Tool and analysis: QDNA, Aurélien Ambert.
  • Analysis (arbitration) completed on September 7, 2026; this page was completed on September 8, 2026 at 01:21 (UTC).
  • Interests: no position in the stock analysed (AXP) is recorded in the data consulted on (UTC). This does not confirm the absence of holdings or other interests. The situation at the analysis publication date has not been reconstructed.
  • This declaration covers only recorded positions in this stock; it is not an exhaustive verification of other interests or remuneration.
  • Methodology: analysis chain, score formula and scale described on the public methodology page.
  • Analysis horizon: 2035.

See also